BRIDGER MANAGEMENT, LLC - Q1 2021 holdings

$1.07 Billion is the total value of BRIDGER MANAGEMENT, LLC's 42 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 48.7% .

 Value Shares↓ Weighting
GDDY SellGODADDY INCcl a$64,599,000
-18.0%
832,253
-12.4%
6.03%
+0.4%
CZR SellCAESARS ENTERTAINMENT INC NE$53,813,000
-34.7%
615,353
-44.6%
5.02%
-20.1%
POST SellPOST HLDGS INC$51,707,000
-6.5%
489,098
-10.6%
4.83%
+14.5%
UBER SellUBER TECHNOLOGIES INC$50,798,000
-2.2%
931,909
-8.5%
4.74%
+19.7%
ALC SellALCON AG$49,204,000
-9.3%
701,115
-14.8%
4.60%
+11.0%
ROST SellROSS STORES INC$46,030,000
-16.7%
383,868
-14.7%
4.30%
+2.0%
MS SellMORGAN STANLEY$45,361,000
+1.3%
584,092
-10.6%
4.24%
+24.0%
HCA BuyHCA HEALTHCARE INC$43,464,000
+21.0%
230,773
+5.6%
4.06%
+48.1%
NTRA SellNATERA INC$39,460,000
-43.7%
388,620
-44.8%
3.68%
-31.0%
SHC NewSOTERA HEALTH CO$38,933,0001,559,828
+100.0%
3.64%
VRSN BuyVERISIGN INC$38,204,000
+2.3%
192,214
+11.4%
3.57%
+25.2%
LKQ SellLKQ CORP$34,642,000
-12.6%
818,387
-27.3%
3.24%
+7.0%
CHTR SellCHARTER COMMUNICATIONS INC Ncl a$33,911,000
-37.7%
54,959
-33.2%
3.17%
-23.7%
FTDR BuyFRONTDOOR INC$32,076,000
+34.5%
596,758
+25.6%
3.00%
+64.7%
GDS SellGDS HLDGS LTDsponsored ads$32,033,000
-25.6%
395,025
-14.1%
2.99%
-8.9%
ALNY SellALNYLAM PHARMACEUTICALS INC$31,980,000
-21.5%
226,504
-27.8%
2.99%
-4.0%
IRWD BuyIRONWOOD PHARMACEUTICALS INC$31,890,000
+13.5%
2,852,414
+15.6%
2.98%
+39.0%
AMWL SellAMERICAN WELL CORPcl a$28,289,000
-75.9%
1,628,617
-64.8%
2.64%
-70.5%
MSFT NewMICROSOFT CORP$26,946,000114,289
+100.0%
2.52%
PODD NewINSULET CORP$24,864,00095,295
+100.0%
2.32%
ATRA BuyATARA BIOTHERAPEUTICS INC$23,976,000
-19.9%
1,669,645
+9.5%
2.24%
-1.9%
CLVT NewCLARIVATE PLC$22,669,000859,000
+100.0%
2.12%
ETSY SellETSY INC$19,716,000
-40.3%
97,763
-47.4%
1.84%
-26.9%
ZGNX NewZOGENIX INC$18,540,000949,813
+100.0%
1.73%
TEVA  TEVA PHARMACEUTICAL INDS LTDsponsored ads$17,310,000
+19.6%
1,500,0000.0%1.62%
+46.4%
FCNCA  FIRST CTZNS BANCSHARES INC Ncl a$16,715,000
+45.5%
20,0000.0%1.56%
+78.2%
DRNA NewDICERNA PHARMACEUTICALS INC$15,058,000588,910
+100.0%
1.41%
PVG  PRETIUM RES INC$14,584,000
-9.7%
1,406,4120.0%1.36%
+10.6%
ZBH  ZIMMER BIOMET HOLDINGS INC$14,258,000
+3.9%
89,0700.0%1.33%
+27.1%
APLS NewAPELLIS PHARMACEUTICALS INC$13,903,000324,000
+100.0%
1.30%
LBRDA  LIBERTY BROADBAND CORP$12,749,000
-7.9%
87,8330.0%1.19%
+12.8%
TGTX  TG THERAPEUTICS INC$12,382,000
-7.3%
256,8970.0%1.16%
+13.4%
AVANU  AVANTI ACQUISITION CORPunit 99/99/9999$10,350,000
-4.5%
1,000,0000.0%0.97%
+16.9%
SQZ  SQZ BIOTECHNOLOGIES CO$9,961,000
-57.5%
807,8270.0%0.93%
-47.9%
CUTR NewCUTERA INC$9,778,000325,400
+100.0%
0.91%
ACAC NewACIES ACQUISITION CORPcl a$8,937,000899,997
+100.0%
0.84%
NEXI NewNEXIMMUNE INC$7,632,000400,000
+100.0%
0.71%
CHFWU  CONSONANCE HFW ACQUISITION Cunit 99/99/9999$6,832,000
-6.8%
700,0000.0%0.64%
+14.1%
SellDERMTECH INC$6,241,000
+6.7%
122,877
-31.9%
0.58%
+30.7%
DXCM SellDEXCOM INC$6,076,000
-37.1%
16,906
-35.3%
0.57%
-23.1%
QTRX SellQUANTERIX CORP$4,517,000
-28.4%
77,249
-43.1%
0.42%
-12.3%
ACACW NewACIES ACQUISITION CORP*w exp 11/30/202$456,000299,999
+100.0%
0.04%
ALEC ExitALECTOR INC$0-229,117
-100.0%
-0.26%
ARNA ExitARENA PHARMACEUTICALS INC$0-68,764
-100.0%
-0.40%
LH ExitLABORATORY CORP AMER HLDGS$0-30,650
-100.0%
-0.48%
ACACU ExitACIES ACQUISITION CORPunit 11/30/2027$0-900,000
-100.0%
-0.74%
LIVN ExitLIVANOVA PLC$0-216,515
-100.0%
-1.09%
INCY ExitINCYTE CORP$0-404,650
-100.0%
-2.68%
MRK ExitMERCK & CO. INC$0-589,461
-100.0%
-3.68%
ALXN ExitALEXION PHARMACEUTICALS INC$0-422,254
-100.0%
-5.03%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERISIGN INC40Q1 20235.2%
TEVA PHARMACEUTICAL INDS LTD40Q3 20237.3%
MORGAN STANLEY35Q3 202311.8%
ALNYLAM PHARMACEUTICALS INC34Q3 20214.9%
POST HLDGS INC33Q4 20226.1%
TG THERAPEUTICS INC33Q3 20213.8%
CHARTER COMMUNICATIONS INC N30Q3 20237.2%
ATARA BIOTHERAPEUTICS INC29Q4 20216.4%
GODADDY INC28Q3 20238.9%
CENTENE CORP DEL28Q3 20226.2%

View BRIDGER MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
BRIDGER MANAGEMENT, LLC Q1 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Surrozen, Inc./DESold outFebruary 14, 202200.0%
Atara Biotherapeutics, Inc.February 16, 20211,524,7601.8%
Dicerna Pharmaceuticals IncFebruary 14, 20201,981,6332.9%
TG THERAPEUTICS, INC.February 14, 20201,907,4921.9%
CHIMERIX INCSold outFebruary 14, 201700.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold outFebruary 14, 201700.0%
SeaSpine Holdings CorpSold outFebruary 14, 201700.0%
Trovagene, Inc.Sold outFebruary 14, 201700.0%
ARROWHEAD RESEARCH CORPSold outFebruary 16, 201600.0%
PENNYMAC FINANCIAL SERVICES, INC.Sold outFebruary 16, 201600.0%

View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14

View BRIDGER MANAGEMENT, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1070847000.0 != 1070844000.0)

Export BRIDGER MANAGEMENT, LLC's holdings